Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Climb Bio, Inc. (CLYM) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Climb Bio, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1768446.
Total stock buying since 2021: $99,952,816.
Total stock sales since 2021: $3,492,701.
Total stock option exercises since 2021: $336.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 23,059 | $28,263 | 128,937 | $0 |
| 2024 | 13,008,546 | $49,952,816 | 485,310 | $3,464,438 | 40,496 | $0 |
| 2023 | 0 | $0 | 0 | $0 | 337,138 | $336 |
| 2021 | 4,000,000 | $50,000,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 21,860 | $26,693 | 98,844 | $0 |
| 2025-03 | 0 | $0 | 1,199 | $1,570 | 30,093 | $0 |
| 2024-12 | 0 | $0 | 1,235 | $2,494 | 5,000 | $0 |
| 2024-09 | 0 | $0 | 1,191 | $9,670 | 5,000 | $0 |
| 2024-07 | 0 | $0 | 481,639 | $3,443,292 | 7,649 | $0 |
| 2024-06 | 13,008,546 | $49,952,816 | 1,245 | $8,982 | 5,000 | $0 |
| 2024-04 | 0 | $0 | 0 | $0 | 17,847 | $0 |
| 2023-09 | 0 | $0 | 0 | $0 | 20,728 | $20 |
| 2023-03 | 0 | $0 | 0 | $0 | 316,410 | $316 |
| 2021-08 | 4,000,000 | $50,000,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-30 | Brennan Aoife (President and CEO) | Sale | 20,618 | 1.22 | 25,153 |
| 2025-06-27 | Thomas Stephen Basil | Option Ex | 25,094 | .00 | 0 |
| 2025-06-27 | Brennan Aoife (President and CEO) | Option Ex | 68,750 | .00 | 0 |
| 2025-06-20 | Pimblett Emily (SVP, Finance & CAO) | Sale | 1,242 | 1.24 | 1,540 |
| 2025-06-18 | Pimblett Emily (SVP, Finance & CAO) | Option Ex | 5,000 | .00 | 0 |
| 2025-03-27 | Thomas Stephen Basil | Option Ex | 25,093 | .00 | 0 |
| 2025-03-20 | Pimblett Emily (SVP, Finance & CAO) | Sale | 1,199 | 1.31 | 1,570 |
| 2025-03-18 | Pimblett Emily (SVP, Finance & CAO) | Option Ex | 5,000 | .00 | 0 |
| 2024-12-19 | Pimblett Emily (CHIEF ACCOUNTING OFFICER) | Sale | 1,235 | 2.02 | 2,494 |
| 2024-12-18 | Pimblett Emily (CHIEF ACCOUNTING OFFICER) | Option Ex | 5,000 | .00 | 0 |
| 2024-09-20 | Pimblett Emily (CHIEF ACCOUNTING OFFICER) | Sale | 1,191 | 8.12 | 9,670 |
| 2024-09-18 | Pimblett Emily (CHIEF ACCOUNTING OFFICER) | Option Ex | 5,000 | .00 | 0 |
| 2024-07-22 | Morisset Valerie (EVP, R&D AND CSO) | Sale | 69,005 | 8.03 | 553,765 |
| 2024-07-19 | Morisset Valerie (EVP, R&D AND CSO) | Sale | 60,201 | 7.17 | 431,340 |
| 2024-07-18 | Morisset Valerie (EVP, R&D AND CSO) | Sale | 38,576 | 6.93 | 267,331 |
| 2024-07-17 | Morisset Valerie (EVP, R&D AND CSO) | Sale | 3,207 | 6.91 | 22,160 |
| 2024-07-16 | Morisset Valerie (EVP, R&D AND CSO) | Sale | 50,000 | 7.13 | 356,500 |
| 2024-07-15 | Morisset Valerie (EVP, R&D AND CSO) | Sale | 42,377 | 7.01 | 297,062 |
| 2024-07-12 | Morisset Valerie (EVP, R&D AND CSO) | Sale | 50,000 | 7.07 | 353,500 |
| 2024-07-11 | Morisset Valerie (EVP, R&D AND CSO) | Sale | 50,000 | 7.11 | 355,500 |
| 2024-07-10 | Morisset Valerie (EVP, R&D AND CSO) | Sale | 50,000 | 6.83 | 341,500 |
| 2024-07-09 | Morisset Valerie (EVP, R&D AND CSO) | Sale | 5,931 | 6.66 | 39,500 |
| 2024-07-05 | Morisset Valerie (EVP, R&D AND CSO) | Sale | 12,342 | 7.06 | 87,134 |
| 2024-07-03 | Morisset Valerie (EVP, R&D AND CSO) | Sale | 50,000 | 6.76 | 338,000 |
| 2024-07-01 | Morisset Valerie (EVP, R&D AND CSO) | Option Ex | 7,649 | .00 | 0 |
| 2024-06-27 | Shah Rajeev M. | Buy | 13,008,546 | 3.84 | 49,952,816 |
| 2024-06-20 | Pimblett Emily (CHIEF ACCOUNTING OFFICER) | Sale | 1,245 | 7.21 | 8,982 |
| 2024-06-18 | Pimblett Emily (CHIEF ACCOUNTING OFFICER) | Option Ex | 5,000 | .00 | 0 |
| 2024-04-05 | Morisset Valerie (EVP, R&D AND CSO) | Option Ex | 17,847 | .00 | 0 |
| 2023-09-20 | Morisset Valerie (EVP, R&D AND CSO) | Option Ex | 20,728 | .00 | 20 |
| 2023-03-10 | Morisset Valerie (EVP, R&D and CSO) | Option Ex | 316,410 | .00 | 316 |
| 2021-08-12 | Shah Rajeev M. | Buy | 3,200,000 | 12.50 | 40,000,000 |
| 2021-08-12 | Blavatnik Len (Other) | Buy | 800,000 | 12.50 | 10,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CLYM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Climb Bio, Inc. (symbol CLYM, CIK number 1768446) see the Securities and Exchange Commission (SEC) website.